Arriving at the Right Diagnosis in an Era of Precision Medicine

被引：0

作者：

Pulido, Vina ^{[1
]}

Lee, Shin Yin ^{[2
]}

Ko, Naomi Yu ^{[2
]}

机构：

[1] Boston Med Ctr, Dept Med, Boston, MA USA

[2] Boston Med Ctr, Dept Med, Hematol Oncol Sect, 801 Massachusetts Ave,First Floor, Boston, MA 02118 USA

来源：

CASE REPORTS IN ONCOLOGY | 2016年 / 9卷 / 02期

关键词：

Thyroid carcinoma; Targeted therapy;

D O I：

10.1159/000447351

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In the era of precision medicine and targeted therapy, diagnostic inaccuracy can have tremendous ramifications. We present the case of a 61-year-old man initially diagnosed with small cell lung cancer by pathology. Prior to initiating chemotherapy, multidisciplinary discussions led to an amendment of the diagnosis to medullary thyroid cancer. (C) 2016 The Author(s) Published by S. Karger AG, Basel

引用

收藏

页码：351 / 357

页数：7

相关论文

共 17 条

[1] Incidentally Discovered Medullary Thyroid Cancer: Diagnostic Strategies and Treatment [J].

Ahmed, Shabina R. ;

Ball, Douglas W. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (05) :1237-1245

[2]

Behr TM, 1997, CANCER-AM CANCER SOC, V80, P2436, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2436::AID-CNCR16>3.3.CO

[3]

2-3

[4] Preoperative diagnosis of medullary thyroid carcinoma: Fine needle aspiration cytology as compared with serum calcitonin measurement [J].

Bugalho, MJM ;

Santos, JR ;

Sobrinho, L .

JOURNAL OF SURGICAL ONCOLOGY, 2005, 91 (01) :56-60

[5] Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules [J].

Costante, Giuseppe ;

Meringolo, Domenico ;

Durante, Cosimo ;

Bianchi, Davide ;

Nocera, Maria ;

Tumino, Salvatore ;

Crocetti, Umberto ;

Attard, Marco ;

Maranghi, Marianna ;

Torlontano, Massimo ;

Filetti, Sebastiano .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (02) :450-455

[6] Increasing incidence of thyroid cancer in the United States, 1973-2002 [J].

Davies, L ;

Welch, HG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (18) :2164-2167

[7] Cabozantinib in Progressive Medullary Thyroid Cancer [J].

Elisei, Rossella ;

Schlumberger, Martin J. ;

Mueller, Stefan P. ;

Schoffski, Patrick ;

Brose, Marcia S. ;

Shah, Manisha H. ;

Licitra, Lisa ;

Jarzab, Barbara ;

Medvedev, Viktor ;

Kreissl, Michael C. ;

Niederle, Bruno ;

Cohen, Ezra E. W. ;

Wirth, Lori J. ;

Ali, Haythem ;

Hessel, Colin ;

Yaron, Yifah ;

Ball, Douglas ;

Nelkin, Barry ;

Sherman, Steven I. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) :3639-+

[8]

Ferreira Carla Vaz, 2013, Cancer Manag Res, V5, P57, DOI 10.2147/CMAR.S33105

[9] CHEMOTHERAPY WITH DACARBAZINE AND 5-FLUOROURACIL IN ADVANCED MEDULLARY-THYROID CANCER [J].

ORLANDI, F ;

CARACI, P ;

BERRUTI, A ;

PULIGHEDDU, B ;

PIVANO, G ;

DOGLIOTTI, L ;

ANGELI, A .

ANNALS OF ONCOLOGY, 1994, 5 (08) :763-765

[10] Prognosis of medullary thyroid carcinoma - Demographic, clinical, and pathologic predictors of survival in 1252 cases [J].

Roman, Sanziana ;

Lin, Rong ;

Sosa, Julie Ann .

CANCER, 2006, 107 (09) :2134-2142